<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The frequency of Strongyloides stercoralis infestation and complication in patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in the United States is unknown </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The authors performed a retrospective analysis of S. stercoralis <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> in patients who were undergoing <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> treatment at The University of Texas M </plain></SENT>
<SENT sid="2" pm="."><plain>D </plain></SENT>
<SENT sid="3" pm="."><plain>Anderson <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Center (Houston, TX) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The overall S. stercoralis <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> frequency was approximately 1.0 per 10,000 new <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cases between 1971 and 2003 </plain></SENT>
<SENT sid="5" pm="."><plain>Twenty-two of 25 patients (88%) were U.S. residents (19 from Texas; 1 each from Mississippi, Tennessee, and Puerto Rico), and the remaining 3 (13%) were from Latin America </plain></SENT>
<SENT sid="6" pm="."><plain>Thirteen (52%) had solid-organ <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, whereas 12 (48%) had <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> (<z:hpo ids='HP_0002665'>lymphoma</z:hpo> or <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo>, n=8; <z:hpo ids='HP_0001909'>leukemia</z:hpo>, n=3; <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, n=1) </plain></SENT>
<SENT sid="7" pm="."><plain>Twelve patients (48%) received systemic <z:chebi fb="0" ids="50858">corticosteroids</z:chebi>, 9 (36%) received <z:chebi fb="0" ids="35610">antineoplastic</z:chebi> therapy, and 2 underwent hematopoietic stem cell transplantation (HSCT) </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0002014'>Diarrhea</z:hpo> was reported in 13 patients (57%), and <z:hpo ids='HP_0001880'>eosinophilia</z:hpo> was observed in 11 patients (48%); 4 patients (16%) had probable hyperinfection syndrome (in 3 cases of polymicrobial <z:mp ids='MP_0001795'>gram-negative</z:mp> <z:e sem="disease" ids="C0004610" disease_type="Disease or Syndrome" abbrv="">bacteremia</z:e>, 1 patient had Klebsiella pneumoniae <z:hpo ids='HP_0002090'>pneumonia</z:hpo>, whereas 1 patient presented with K. pneumoniae <z:e sem="disease" ids="C0876973" disease_type="Disease or Syndrome" abbrv="">lung infection</z:e> alone) </plain></SENT>
<SENT sid="9" pm="."><plain>Evidence of definite pulmonary hyperinfection syndrome was observed in 2 HSCT recipients (8%) </plain></SENT>
<SENT sid="10" pm="."><plain>Fourteen (74%) of 19 patients responded to <z:chebi fb="1" ids="45979">thiabendazole</z:chebi> therapy </plain></SENT>
<SENT sid="11" pm="."><plain>Two patients with definite pulmonary hyperinfection syndrome developed fatal S. stercoralis hemorrhagic <z:mp ids='MP_0010922'>alveolitis</z:mp> despite receiving high-dose <z:chebi fb="1" ids="45979">thiabendazole</z:chebi> plus ivermectin therapy </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: In the current study, <z:e sem="disease" ids="C0038463" disease_type="Disease or Syndrome" abbrv="">strongyloidiasis</z:e> was uncommon in patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and remained localized in individuals with solid-organ <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>Definite pulmonary accelerated autoinfections were observed only in HSCT recipients </plain></SENT>
<SENT sid="14" pm="."><plain>Therefore, pre-HSCT S. stercoralis screening in individuals from endemic regions of the United States warrants further study </plain></SENT>
</text></document>